Tuesday, March 02, 2010

AmnisNews: FDA panel backs Bristol transplant drug: WASHINGTON (Reuters) - Bristol-Myers Squibb Co'.. http://bit.ly/9JBfHD
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)